News 

 

Click on our social media addresses to see news from Menarini Turkey.

 

icone_facebook   icone_instagram   icone_linkedin   icona_youtube

 


Fair Play Menarini International Award announcing the winners of the 28th edition at the CONI headquarters

ROME, 5 June 2024 – The wait is finally over - new sporting stars light up the world of the Fair Play Menarini International Award. The annual event, that promotes the values of ethics, loyalty and respect, officially kicked off this morning at the CONI headquarters’ Hall of Honour with the press conference to present the 28th edition, to be held on July 3 and 4 in Florence and Fiesole. The Fair Play Menarini Foundation has announced the names of the winners who will receive the prestigious award on the evening of July 4 on the stage of the Roman Theatre in Fiesole.

Fair Play Menarini International Award, here are the dates of the 2024 edition

FLORENCE, May 14th 2024 – Preparations are in full swing for the upcoming Fair Play Menarini International Award, the event that, every year, celebrates athletes who have become global standard bearers of ethics, loyalty and respect.

Fair Play Menarini International Awards, the champions of Fair Play cast their spell on the audience in Fiesole

FLORENCE, July 6th, 2023 – Yesterday evening, the grand finale of the XXVII edition of the Menarini International Fair Play Awards was warmly greeted by over one thousand spectators at the Roman Theatre in Fiesole. The event, organised by the Menarini Fair Play Foundation and focused on the culture of fair play and respect in sport, drew to a close for the first time on this magnificent stage.

Botticelli, the inquietude and the beauty

FLORENCE, Italy, 14th May 2023 -- Successful artist, sensitive interpreter of the culture of his time and author of extraordinarily relevant works, Sandro Botticelli was a master of beauty.  With his “Venuses,” he unknowingly established a canon of perfection that closely reflects that of modern day. 

Menarini Group’s Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced Metastatic Breast Cancer

FLORENCE, Italy and NEW YORK, NY, August 19, 2022 -- The Menarini Group (“Menarini”), a privately held Italian pharmaceutical and diagnostics company, and Stemline Therapeutics (“Stemline”), a wholly-owned subsidiary of the Menarini Group, today announced that EMA has validated the Marketing Authorization Application (MAA) for elacestrant, a selective estrogen receptor degrader (SERD), for patients with ER+/HER2- advanced or metastatic breast cancer. Validation of the application confirms the submission is complete and begins EMA’s centralized review procedure.

History

The origins of the menarini date back to 1886, when Archimede Menarini opened, in the center of naples, the “Farmacia Internazionale".

 

About Us

Menarini Group operates in 140 countries around the world.

Read More »

Mission, Vision &
Our Values

Everyday we put our values into action. 8 values, which have given life to Menarini and have shaped its history.

Menarini
in the World

To see the activities of the Menarini Group in other countries.
Scroll Top